share_log

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Growth Equity Opportunities Fund IV, LLC(15.1%),New Enterprise Associates 15, L.P.(15.1%), etc.

SEC ·  Aug 24, 2022 05:18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more